Zhao Ling, Lan Liu-gui, Min Xiao-li, Lu Ai-hua, Zhu Li-qun, He Xiao-hong, He Ling-jie
Department of Endocrinology, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2007 Jul;27(7):1052-5.
To study the therapeutic effect of traditional Chinese herbal medicinal preparation Tangshenqing (TSQ) combined with alprostadil in the treatment of early- and intermediate-stage diabetic nephropathy (DN).
One hundred and twenty DN patients were randomized into 3 groups for different treatment protocols. The patients in the control group were given the basic treatment (low-protein diabetic diet and rigorous control of blood glucose, blood pressure, and blood fatty acid), and those in treatment group A received TSQ (containing Astragalus membranaceus, Panax notoginseng, Epimedium brevicornum, etc) in addition to the basic treatment, and those in treatment group B were treated with alprostadil injections (for 14 consecutive days) in addition to the treatment given in group A. Therapeutic effect evaluation was carried out after a 30-day treatment in all the patients.
The overall efficaey rate of the treatment was 78.37% in the control group, 88.57% in the treatment group A, and 94.44% in treatment group B, suggesting better therapeutic effect in the latter two groups than in the control group (P<0.05). Patients in all the 3 groups exhibited symptomatic improvement of various degrees, but the treatment group B had the best results. After the treatments, the patients' blood glucose and fatty acids were lowered, without obvious difference between the 3 groups. Compared with the control group, the patients in the two treatment groups showed significant reduction in fibrinogen, 24-h urine microprotein and urine protein after the treatment (P<0.01 or 0.05).
Combined use of traditional Chinese herbal medicine TSQ and alprostadil injections produces definite therapeutic effect on early- to intermediate-stage DN.
研究中药制剂糖肾清(TSQ)联合前列地尔治疗早、中期糖尿病肾病(DN)的疗效。
将120例DN患者随机分为3组,给予不同治疗方案。对照组患者给予基础治疗(低蛋白糖尿病饮食并严格控制血糖、血压和血脂),治疗组A在基础治疗的基础上给予TSQ(含黄芪、三七、淫羊藿等),治疗组B在治疗组A的治疗基础上给予前列地尔注射液治疗(连续14天)。所有患者治疗30天后进行疗效评估。
对照组总有效率为78.37%,治疗组A为88.57%,治疗组B为94.44%,后两组疗效优于对照组(P<0.05)。3组患者均有不同程度的症状改善,但治疗组B效果最佳。治疗后,患者血糖和血脂降低,3组间无明显差异。与对照组相比,两个治疗组患者治疗后纤维蛋白原、24小时尿微量蛋白和尿蛋白均显著降低(P<0.01或0.05)。
中药TSQ联合前列地尔注射液治疗早、中期DN有确切疗效。